These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
321 related items for PubMed ID: 18552693
1. Increased levels of soluble triggering receptor expressed on myeloid cells-1 in patients with acute pancreatitis. Yasuda T, Takeyama Y, Ueda T, Shinzeki M, Sawa H, Takahiro N, Kamei K, Ku Y, Kuroda Y, Ohyanagi H. Crit Care Med; 2008 Jul; 36(7):2048-53. PubMed ID: 18552693 [Abstract] [Full Text] [Related]
2. Soluble triggering receptor expressed on myeloid cell-1 (sTREM-1): a new mediator involved in early ankylosing spondylitis. Chen CH, Liao HT, Chen HA, Liang TH, Wang CT, Chou CT. J Rheumatol; 2008 Sep; 35(9):1846-8. PubMed ID: 18634145 [Abstract] [Full Text] [Related]
4. Serum interleukin-15 level is a useful predictor of the complications and mortality in severe acute pancreatitis. Ueda T, Takeyama Y, Yasuda T, Shinzeki M, Sawa H, Nakajima T, Takase K, Matsumoto I, Fujita T, Ajiki T, Fujino Y, Kuroda Y. Surgery; 2007 Sep; 142(3):319-26. PubMed ID: 17723882 [Abstract] [Full Text] [Related]
5. Evidence for the participation of soluble triggering receptor expressed on myeloid cells-1 in the systemic inflammatory response syndrome after multiple trauma. Giamarellos-Bourboulis EJ, Mouktaroudi M, Tsaganos T, Koutoukas P, Spyridaki E, Pelekanou A, Kotzampassi K. J Trauma; 2008 Dec; 65(6):1385-90. PubMed ID: 19077631 [Abstract] [Full Text] [Related]
10. Early serum levels of soluble triggering receptor expressed on myeloid cells-1 in septic patients: correlation with monocyte gene expression. Dimopoulou I, Pelekanou A, Mavrou I, Savva A, Tzanela M, Kotsaki A, Kardara M, Orfanos SE, Kotanidou A, Giamarellos-Bourboulis EJ. J Crit Care; 2012 Jun; 27(3):294-300. PubMed ID: 21855288 [Abstract] [Full Text] [Related]
11. Diagnostic accuracy of sTREM-1 to identify infection in critically ill patients with systemic inflammatory response syndrome. Latour-Pérez J, Alcalá-López A, García-García MA, Sánchez-Hernández JF, Abad-Terrado C, Viedma-Contreras JA, Masiá M, González-Tejera M, Arizo-León D, Porcar MJ, Bonilla-Rovira F, Gutiérrez F. Clin Biochem; 2010 Jun; 43(9):720-4. PubMed ID: 20303344 [Abstract] [Full Text] [Related]
12. Soluble TREM-1 is not suitable for distinguishing between systemic inflammatory response syndrome and sepsis survivors and nonsurvivors in the early stage of acute inflammation. Bopp C, Hofer S, Bouchon A, Zimmermann JB, Martin E, Weigand MA. Eur J Anaesthesiol; 2009 Jun; 26(6):504-7. PubMed ID: 19307971 [Abstract] [Full Text] [Related]
17. Triggering receptor expressed on myeloid cells-1 in pleural effusions: a marker of inflammatory disease. Liu CL, Hsieh WY, Wu CL, Kuo HT, Lu YT. Respir Med; 2007 May 05; 101(5):903-9. PubMed ID: 17097866 [Abstract] [Full Text] [Related]
18. Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) detection in cancer patients: a prognostic marker for lung metastases from solid malignancies. Karapanagiotou EM, Pelekanou E, Charpidou A, Tsaganos T, Anagnostou V, Plachouras D, Giamarellos-Bourboulis EJ, Syrigos KN. Anticancer Res; 2008 May 05; 28(2B):1411-5. PubMed ID: 18505088 [Abstract] [Full Text] [Related]